• Chamber raised USD 60 million in Series A funding led by Frist Cressey Ventures to expand cardiology-focused value-based care.
• The company partners with health plans and cardiology practices to manage heart disease under risk-based models.
• Chamber’s platform uses workflow-native AI to flag high-risk patients, surface therapy gaps, reduce manual chart review.
• Proceeds target additional health plan partnerships, new markets, team growth across clinical, operations, technology.
• The financing also included debt from HSBC Innovation Banking.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Frist Cressey Ventures LLC published the original content used to generate this news brief on August 18, 2026, and is solely responsible for the information contained therein.